annual D&A:
$43.55M+$5.03M(+13.04%)Summary
- As of today (September 16, 2025), TVTX annual depreciation & amortization is $43.55 million, with the most recent change of +$5.03 million (+13.04%) on December 31, 2024.
- During the last 3 years, TVTX annual D&A has risen by +$16.94 million (+63.64%).
- TVTX annual D&A is now at all-time high.
Performance
TVTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$14.02M+$1.21M(+9.48%)Summary
- As of today (September 16, 2025), TVTX quarterly depreciation & amortization is $14.02 million, with the most recent change of +$1.21 million (+9.48%) on June 30, 2025.
- Over the past year, TVTX quarterly D&A has increased by +$3.67 million (+35.49%).
- TVTX quarterly D&A is now -16.72% below its all-time high of $16.83 million, reached on June 30, 2023.
Performance
TVTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$50.15M+$3.67M(+7.90%)Summary
- As of today (September 16, 2025), TVTX TTM depreciation & amortization is $50.15 million, with the most recent change of +$3.67 million (+7.90%) on June 30, 2025.
- Over the past year, TVTX TTM D&A has increased by +$14.84 million (+42.04%).
- TVTX TTM D&A is now at all-time high.
Performance
TVTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TVTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.0% | +35.5% | +42.0% |
| 3 y3 years | +63.6% | +72.9% | +72.2% |
| 5 y5 years | +113.4% | +139.6% | +126.2% |
TVTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.2% | -16.7% | +1867.5% | at high | +147.7% |
| 5 y | 5-year | at high | +113.4% | -16.7% | +1867.5% | at high | +147.7% |
| alltime | all time | at high | >+9999.0% | -16.7% | +1867.5% | at high | >+9999.0% |
TVTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $14.02M(+9.5%) | $50.15M(+7.9%) |
| Mar 2025 | - | $12.80M(+5.9%) | $46.48M(+6.7%) |
| Dec 2024 | $43.55M(+13.0%) | $12.09M(+7.6%) | $43.55M(+6.4%) |
| Sep 2024 | - | $11.24M(+8.6%) | $40.95M(+16.0%) |
| Jun 2024 | - | $10.35M(+4.7%) | $35.31M(-15.5%) |
| Mar 2024 | - | $9.88M(+4.1%) | $41.79M(+8.5%) |
| Dec 2023 | $38.53M(+86.0%) | $9.49M(+69.6%) | $38.53M(+9.0%) |
| Sep 2023 | - | $5.59M(-66.8%) | $35.35M(+22.0%) |
| Jun 2023 | - | $16.83M(+154.2%) | $28.97M(+43.1%) |
| Mar 2023 | - | $6.62M(+4.9%) | $20.25M(-2.3%) |
| Dec 2022 | $20.72M(-22.2%) | $6.31M(-896.0%) | $20.72M(+1.3%) |
| Sep 2022 | - | -$793.00K(-109.8%) | $20.46M(-29.8%) |
| Jun 2022 | - | $8.11M(+14.3%) | $29.12M(+5.4%) |
| Mar 2022 | - | $7.09M(+17.2%) | $27.64M(+3.8%) |
| Dec 2021 | $26.62M(+3.2%) | $6.05M(-23.2%) | $26.62M(-6.3%) |
| Sep 2021 | - | $7.87M(+18.9%) | $28.41M(+5.3%) |
| Jun 2021 | - | $6.62M(+9.0%) | $26.98M(+2.9%) |
| Mar 2021 | - | $6.07M(-22.5%) | $26.21M(+1.6%) |
| Dec 2020 | $25.79M(+26.4%) | $7.84M(+21.8%) | $25.79M(+11.0%) |
| Sep 2020 | - | $6.44M(+10.0%) | $23.24M(+4.8%) |
| Jun 2020 | - | $5.85M(+3.4%) | $22.17M(+4.8%) |
| Mar 2020 | - | $5.66M(+6.9%) | $21.16M(+3.7%) |
| Dec 2019 | $20.41M(+9.3%) | $5.29M(-1.6%) | $20.41M(+2.1%) |
| Sep 2019 | - | $5.38M(+11.1%) | $20.00M(+3.0%) |
| Jun 2019 | - | $4.84M(-1.2%) | $19.42M(+1.0%) |
| Mar 2019 | - | $4.90M(+0.5%) | $19.22M(+3.0%) |
| Dec 2018 | $18.67M(+4.9%) | $4.88M(+1.7%) | $18.67M(+2.3%) |
| Sep 2018 | - | $4.80M(+3.3%) | $18.26M(+1.0%) |
| Jun 2018 | - | $4.64M(+6.8%) | $18.07M(+1.2%) |
| Mar 2018 | - | $4.35M(-2.7%) | $17.87M(+0.4%) |
| Dec 2017 | $17.80M | $4.47M(-3.2%) | $17.80M(+1.6%) |
| Sep 2017 | - | $4.62M(+4.0%) | $17.52M(+3.1%) |
| Jun 2017 | - | $4.44M(+3.6%) | $17.00M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $4.28M(+2.4%) | $16.53M(+2.4%) |
| Dec 2016 | $16.14M(+20.5%) | $4.18M(+2.1%) | $16.14M(+1.3%) |
| Sep 2016 | - | $4.09M(+3.2%) | $15.93M(+1.4%) |
| Jun 2016 | - | $3.97M(+2.0%) | $15.71M(+1.4%) |
| Mar 2016 | - | $3.89M(-2.1%) | $15.50M(+15.8%) |
| Dec 2015 | $13.39M(+148.0%) | $3.98M(+2.4%) | $13.39M(+18.8%) |
| Sep 2015 | - | $3.88M(+3.3%) | $11.28M(+22.0%) |
| Jun 2015 | - | $3.76M(+111.2%) | $9.24M(+31.1%) |
| Mar 2015 | - | $1.78M(-4.3%) | $7.05M(+30.6%) |
| Dec 2014 | $5.40M(+2400.5%) | $1.86M(+0.4%) | $5.40M(+50.0%) |
| Sep 2014 | - | $1.85M(+18.2%) | $3.60M(+99.6%) |
| Jun 2014 | - | $1.57M(+1130.7%) | $1.80M(+519.7%) |
| Mar 2014 | - | $127.20K(+123.6%) | $291.00K(+34.7%) |
| Dec 2013 | $216.00K(+72.9%) | $56.90K(+5.8%) | $216.00K(+35.8%) |
| Sep 2013 | - | $53.80K(+1.3%) | $159.10K(+51.1%) |
| Jun 2013 | - | $53.10K(+1.7%) | $105.30K(+101.7%) |
| Mar 2013 | - | $52.20K(>+9900.0%) | $52.20K(>+9900.0%) |
| Dec 2012 | $124.90K(>+9900.0%) | - | - |
| Nov 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2008 | - | $0.00 | $0.00 |
| Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual D&A year-on-year change?
- What is Travere Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Travere Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM D&A year-on-year change?
What is Travere Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of TVTX is $43.55M
What is the all time high annual D&A for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual depreciation & amortization is $43.55M
What is Travere Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, TVTX annual depreciation & amortization has changed by +$5.03M (+13.04%)
What is Travere Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of TVTX is $14.02M
What is the all time high quarterly D&A for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly depreciation & amortization is $16.83M
What is Travere Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, TVTX quarterly depreciation & amortization has changed by +$3.67M (+35.49%)
What is Travere Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of TVTX is $50.15M
What is the all time high TTM D&A for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM depreciation & amortization is $50.15M
What is Travere Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, TVTX TTM depreciation & amortization has changed by +$14.84M (+42.04%)